https://www.zonebourse.com/cours/action/IRLAB-THERAPEUTICS-AB-61747292/actualite/IRLAB-Therapeutics-AB-recoit-un-brevet-supplementaire-pour-le-candidat-medicament-Pirepemat-qui--45548732/?utm_source=telegram&utm_medium=social&utm_campaign=share